These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 23552414)
1. Vesicular stomatitis virus variants selectively infect and kill human melanomas but not normal melanocytes. Wollmann G; Davis JN; Bosenberg MW; van den Pol AN J Virol; 2013 Jun; 87(12):6644-59. PubMed ID: 23552414 [TBL] [Abstract][Full Text] [Related]
2. Variation in susceptibility of human malignant melanomas to oncolytic vesicular stomatitis virus. Blackham AU; Northrup SA; Willingham M; D'Agostino RB; Lyles DS; Stewart JH Surgery; 2013 Mar; 153(3):333-43. PubMed ID: 23102637 [TBL] [Abstract][Full Text] [Related]
3. Some attenuated variants of vesicular stomatitis virus show enhanced oncolytic activity against human glioblastoma cells relative to normal brain cells. Wollmann G; Rogulin V; Simon I; Rose JK; van den Pol AN J Virol; 2010 Feb; 84(3):1563-73. PubMed ID: 19906910 [TBL] [Abstract][Full Text] [Related]
7. The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma. Kimpel J; Urbiola C; Koske I; Tober R; Banki Z; Wollmann G; von Laer D Viruses; 2018 Mar; 10(3):. PubMed ID: 29498639 [TBL] [Abstract][Full Text] [Related]
8. Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis. Westcott MM; Liu J; Rajani K; D'Agostino R; Lyles DS; Porosnicu M J Virol; 2015 Aug; 89(15):7944-54. PubMed ID: 25995245 [TBL] [Abstract][Full Text] [Related]
9. Curcumin promotes the oncoltyic capacity of vesicular stomatitis virus for the treatment of prostate cancers. Fehl DJ; Ahmed M Virus Res; 2017 Jan; 228():14-23. PubMed ID: 27865863 [TBL] [Abstract][Full Text] [Related]
10. Triptolide-mediated inhibition of interferon signaling enhances vesicular stomatitis virus-based oncolysis. Ben Yebdri F; Van Grevenynghe J; Tang VA; Goulet ML; Wu JH; Stojdl DF; Hiscott J; Lin R Mol Ther; 2013 Nov; 21(11):2043-53. PubMed ID: 23985699 [TBL] [Abstract][Full Text] [Related]
11. Attenuation of vesicular stomatitis virus infection of brain using antiviral drugs and an adeno-associated virus-interferon vector. Wollmann G; Paglino JC; Maloney PR; Ahmadi SA; van den Pol AN Virology; 2015 Jan; 475():1-14. PubMed ID: 25462341 [TBL] [Abstract][Full Text] [Related]
12. Oncolytic measles and vesicular stomatitis virotherapy for endometrial cancer. Liu YP; Steele MB; Suksanpaisan L; Federspiel MJ; Russell SJ; Peng KW; Bakkum-Gamez JN Gynecol Oncol; 2014 Jan; 132(1):194-202. PubMed ID: 24246772 [TBL] [Abstract][Full Text] [Related]
13. Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate Cancer. Yu N; Puckett S; Antinozzi PA; Cramer SD; Lyles DS J Virol; 2015 May; 89(10):5250-63. PubMed ID: 25741004 [TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis in pancreatic cancer cells by vesicular stomatitis virus. Felt SA; Moerdyk-Schauwecker MJ; Grdzelishvili VZ Virology; 2015 Jan; 474():163-73. PubMed ID: 25463614 [TBL] [Abstract][Full Text] [Related]
15. Single-cycle viral gene expression, rather than progressive replication and oncolysis, is required for VSV therapy of B16 melanoma. Galivo F; Diaz RM; Wongthida P; Thompson J; Kottke T; Barber G; Melcher A; Vile R Gene Ther; 2010 Feb; 17(2):158-70. PubMed ID: 20016540 [TBL] [Abstract][Full Text] [Related]
16. Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling. Moerdyk-Schauwecker M; Shah NR; Murphy AM; Hastie E; Mukherjee P; Grdzelishvili VZ Virology; 2013 Feb; 436(1):221-34. PubMed ID: 23246628 [TBL] [Abstract][Full Text] [Related]
17. Highly attenuated recombinant vesicular stomatitis virus VSV-12'GFP displays immunogenic and oncolytic activity. van den Pol AN; Davis JN J Virol; 2013 Jan; 87(2):1019-34. PubMed ID: 23135719 [TBL] [Abstract][Full Text] [Related]
18. Oncolytic Recombinant Vesicular Stomatitis Virus (VSV) Is Nonpathogenic and Nontransmissible in Pigs, a Natural Host of VSV. Velazquez-Salinas L; Naik S; Pauszek SJ; Peng KW; Russell SJ; Rodriguez LL Hum Gene Ther Clin Dev; 2017 Jun; 28(2):108-115. PubMed ID: 28514874 [TBL] [Abstract][Full Text] [Related]
19. Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β. Naik S; Nace R; Barber GN; Russell SJ Cancer Gene Ther; 2012 Jul; 19(7):443-50. PubMed ID: 22522623 [TBL] [Abstract][Full Text] [Related]
20. Vesicular Stomatitis Virus (VSV) G Glycoprotein Can Be Modified to Create a Her2/Neu-Targeted VSV That Eliminates Large Implanted Mammary Tumors. Gao Y; Bergman I J Virol; 2023 Jun; 97(6):e0037223. PubMed ID: 37199666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]